Editas Medicine (EDIT) FCF Margin (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 99,597.00 |
| Jun 30, 2025 | -37,474.00 |
| Mar 31, 2025 | -88,961.00 |
| Dec 31, 2024 | 9.09 Mn |
| Sep 30, 2024 | -7.92 Mn |
| Jun 30, 2024 | -724,543.00 |
| Mar 31, 2024 | -452,609.00 |
| Dec 31, 2023 | 69,173.00 |
| Sep 30, 2023 | 55,999.00 |
| Jun 30, 2023 | -90,271.00 |
| Mar 31, 2023 | 27,455.00 |
| Dec 31, 2022 | 12.17 Mn |
| Sep 30, 2022 | -12.18 Mn |
| Jun 30, 2022 | 19,871.00 |
| Mar 31, 2022 | -48,166.00 |
| Dec 31, 2021 | 37,180.00 |
| Sep 30, 2021 | 989,106.00 |
| Jun 30, 2021 | -977,880.00 |
| Mar 31, 2021 | -41,368.00 |
| Dec 31, 2020 | -26,664.00 |
| Sep 30, 2020 | 22,189.00 |
| Jun 30, 2020 | 67,848.00 |
| Mar 31, 2020 | -134,714.00 |
| Dec 31, 2019 | 117,695.00 |
| Sep 30, 2019 | 28,392.00 |
| Jun 30, 2019 | 32,260.00 |
| Mar 31, 2019 | -148,448.00 |
| Dec 31, 2018 | 13,993.00 |
| Sep 30, 2018 | 15,582.00 |
| Jun 30, 2018 | 34,496.00 |
| Sep 30, 2017 | -115,490.00 |
| Jun 30, 2017 | -876,122.00 |
| Mar 31, 2017 | 1.20 Mn |
| Dec 31, 2016 | -30,679.00 |
| Sep 30, 2016 | -123,931.00 |
| Jun 30, 2016 | 92,274.00 |
| Mar 31, 2016 | -19,975.00 |
| Dec 31, 2015 | 74,871.00 |
| Sep 30, 2015 | -1.36 Mn |